Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0364020090420060732
Korean Journal of Thoracic and Cardiovascular Surgery
2009 Volume.42 No. 6 p.732 ~ p.737
Video-Assisted Thoracic Surgery Lobectomy: Experience with 36 Cases
Lee Hee-Sung

Kim Hyung-Soo
Kim Kun-Il
Lee Jae-Woong
Shin Ho-Seung
Cho Sung-Woo
Shin Yoon-Cheol
Park Sang-Jun
Abstract
Background: Many video-assisted thoracic surgery (VATS) lobectomies are performed as a potential alternative to thoracotomy despite the controversy about the safety and the associated morbidity/mortality rates.

Material and Method: Between November 2006 and August 2008, we performed 87 lobectomies (VATS 36, Thoracotomy 51) and we retrospectively reviewed the surgical treatment results. A VATS lobectomy was performed by a 4¡­5 cm thoracotomy without rib spreading and this included anatomic hilar dissection, individual vessel and bronchus stapling and lymph node dissection.

Result: We studied 52 male and 35 female patients whose age ranged from 6 to 79 (average age: 59.8¡¾15.0 years). The cases were diagnosed with lung cancer (66) (SQC 24, ADC 38, others 4), pulmonary metastasis (2), carcinoid (2) and benign diseases (17). There was no intraoperative death. Postoperative complications were seen in 5 (15.6%) VATS and 33 (64.7%) thoracotomies, and perioperative death caused by adult respiratory distress syndrome occurred in 1 (2.8%) VATS and 3 (5.9%) thoracotomies. Three patients underwent conversion to thoracotomy (8.3%). The mean time to chest tube removal was 6 days for VATS and 9.4 days for thoracotomy (p£¼0.001), and the mean length of the hospital stay was 8 days for VATS and 12.8 days for thoracotomy (p£¼0.001).

Conclusion: VATS lobectomy can be performed safely with low morbidity/mortality rates. Furthermore, all the patients benefited from earlier postoperative rehabilitation and less pain and they were candidates for an earlier return to normal activities.
KEYWORD
Video-assisted thoracic surgery (VATS), Lobectomy
FullTexts / Linksout information
  
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø